Updates

Cohort - 22% organic revenue growth in FY15

July 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Cohort has reported results that were as good as had been expected. Overall, sales climbed 40% to £100m with adjusted pretax profit up 23% to £10.2m. Earnings were up 7% to 20.5p. Impressively, all the divisions grew sales and profit. SCS, the defence consultancy, built on the recovery seen last year with a £1.3m profit on sales of £16.9m. Chief executive Andrew Thomis says the order cover and the prospects mean that the recovery looks sustainable.The high margin side of the group is, of course, Mass, which grew profit by 10% to £5.5m on sales of £32.5m (£27.6m). Its net margin was down from 18.1% to 16.9% as a result of changed mix. This was driven by electronic war ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

SQS - Quadruples US presence with acquisition

First Derivatives - Software run rate of £37m-£39m

Cohort (February 2018)

Cohort (January 2017)

Cohort - Defence firm posts record profits (August 2016)

Cohort (January 2016)

Cohort - Eps enhancing deal in Portugal; gain since January 58% (September 2015)

Cohort (May 2015)

Cohort - Defence business with £147m order book on a tear (March 2015)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X